SPX3,693.23-64.76 -1.72%
DIA295.86-4.66 -1.55%
IXIC10,867.93-198.88 -1.80%

Morgan Stanley Raises Price Target on Akero Therapeutics to $30 From $26, Reiterates Equalweight Rating

Morgan Stanley Raises Price Target on Akero Therapeutics to $30 From $26, Reiterates Equalweight Rating

MT Newswires · 09/14/2022 06:18

Please log in to view news